Gf Fund Management »

Summit Therapeutics shares owned by Gf Fund Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Gf Fund Management from 13F filings

Historical chart of Gf Fund Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Gf Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Gf Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $330k 16k 20.66
2025-06-30 $402k 19k 21.28
2025-03-31 $376k 20k 19.29
2024-12-31 $302k 17k 17.85

More positions owned by Gf Fund Management

NVIDIA Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Broadcom Common Stock (AVGO)
Amazon.com Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOG)
Tesla Common Stock (TSLA)
Alphabet Common Stock (GOOGL)
PDD Holdings Adr (PDD)
Netflix Common Stock (NFLX)
Costco Wholesale Corp Common Stock (COST)
Palantir Technologies Common Stock (PLTR)
Lumentum Holdings Common Stock (LITE)
Advanced Micro Devices Common Stock (AMD)

View all positions for Gf Fund Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics